| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.764 | 66.744 | 70.810 | 109.051 | 121.462 | 124.131 | 137.401 | 167.585 | 191.731 | 202.855 |
| Total Income - EUR | 62.765 | 66.744 | 70.810 | 109.052 | 121.463 | 124.132 | 137.420 | 167.586 | 191.732 | 202.856 |
| Total Expenses - EUR | 51.448 | 47.052 | 48.609 | 71.704 | 69.792 | 67.025 | 79.560 | 61.660 | 92.333 | 103.044 |
| Gross Profit/Loss - EUR | 11.317 | 19.692 | 22.201 | 37.348 | 51.671 | 57.106 | 57.860 | 105.926 | 99.398 | 99.811 |
| Net Profit/Loss - EUR | 8.732 | 19.025 | 21.304 | 36.257 | 50.456 | 55.947 | 56.802 | 104.284 | 97.519 | 93.847 |
| Employees | 7 | 7 | 7 | 6 | 6 | 6 | 5 | 4 | 4 | 3 |
Check the financial reports for the company - Silianmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.794 | 7.119 | 6.416 | 4.258 | 3.079 | 99.023 | 104.435 | 92.238 | 166.587 | 137.336 |
| Current Assets | 64.709 | 20.838 | 21.948 | 37.082 | 51.733 | 45.021 | 21.782 | 58.893 | 72.530 | 26.584 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.166 | 4.816 | 5.400 | 9.208 | 36.322 | 44.051 | 10.305 | 57.339 | 64.800 | 8.181 |
| Cash | 60.543 | 16.022 | 16.547 | 27.875 | 15.411 | 969 | 11.477 | 1.554 | 7.730 | 18.403 |
| Shareholders Funds | 60.973 | 19.070 | 21.348 | 36.300 | 50.499 | 55.988 | 56.842 | 104.324 | 97.560 | 93.888 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.530 | 8.888 | 7.015 | 5.040 | 4.313 | 88.056 | 69.375 | 46.807 | 148.717 | 73.345 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Silianmed Srl